pharma
Angelini Pharma S.p.A
Angelini Pharma S.p.A patent portfolio — 7 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- ROMA, IT
- Programs
- 0
- Drugs
- 0
- Patents
- 7
Angelini Pharma S.p.A patents
7 pharmaceutical patents indexed for Angelini Pharma S.p.A. 0 expire within 24 months.
Angelini Pharma S.p.A has 7 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
WO 2025252600
COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3
granted -
WO 2025252599
COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3
granted -
AU 2024268154
NOVEL CARBOXAMIDE DERIVATIVES
granted -
IT 202300027246
Matrici farmaceutiche per il rilascio prolungato di farmaci
granted -
IT 202200024948
Composti attivatori dei canali potassio KV7.2/KV7.3
granted -
IT 202200024963
Composti attivatori dei canali potassio Kv7.2/Kv7.3
granted -
AU 2022390453
NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS
granted
Frequently asked questions
How many patents does Angelini Pharma S.p.A have?
7 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Angelini Pharma S.p.A patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.